Home » Topics » BioWorld

BioWorld
RSS

INTERNEURON DENIES DRUG TOXICITY

Dec. 31, 1991

THE YEAR AHEAD: BIOTECH LEGISLATION

Dec. 30, 1991

APPOINTMENTS AND ADVANCEMENTS

Dec. 30, 1991

SYNERGEN, XOMA STOCK UP

Dec. 30, 1991

CDC FINALIZES VACCINATION RECOMMENDATION

Dec. 30, 1991

CROP, DU PONT SIGN DEAL FOR INSECTICIDES

Dec. 30, 1991

MACRONEX RAISES $2 MILLION IN FINANCING

Dec. 27, 1991

UNIVAX 'SILENT FILING' FOR IPO

Dec. 27, 1991

EMBREX HATCHES DEAL FOR MODIFYING POULTRY

Dec. 27, 1991

CHIRON, CIBA REVISE VACCINE AGREEMENTS

Dec. 27, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...